FDA-AstraZeneca Hearing
Drug Safety Issues: Psychotropic Drugs
Why is FDA Silent? Seroquel Victim Asked Judge to Unseal Documents for FDA Advisory
Three years have elapsed since FDA medical officers reported the findings of their comprehensive review of clinical trial data at an FDA pediatric advisory committee hearing (March, 2006).
"There is altogether too much secrecy in court cases that implicate public health."
“Bitter Pill” by Ben Wallace-Wells in the current issue of Rolling Stone is an excellent, informative, in-depth article providing an overview into the pharmaceutical industry’s immensely successful—albeit illegal—aggressive marketing tactics, for selling a particularly unsafe, dangerous class of drugs—the antipsychotics, Zyprexa in particular.
Using drugs to cope with battlefield traumas is not discussed much outside the Army, but inside the service it has been the subject of debate for years.
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
Good news but continued vigilance required! A backlash by outraged parents and advocates for responsible evidence-based rhetoric about physical and mental health issues, forced Dr. Harold Koplewicz, founder and director of the NYU Child Study Center, to pull the irresponsible, fear mongering "ransom note" ad campaign in which threats and…
When scientists are for sale and "peer reviewed" journals publish planted commercial pronouncements masquerading as "science" news reports, the public is advised to disregard those "news" reports and wait for the evidence to be independently examined and either corroborated or refuted.
A scientifically invalid study by financially compromised psychiatrists is but industy’s latest effort to rehabilitate SSRI antidepressants in the wake of public disclosure that these drugs DOUBLED the risk of suicidal acts.
The chemical abuse of U.S. children in foster care represent the collapse of civilized medicine.
A First Amendment lawyer challenges the rationale given by Judge Jack Weinstein for sealing the Zyprexa documents in the first place.